Xaluprine 20 mg/ml oral suspension *
Pharmacy Only: Prescription

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 13 January 2022

File name

SPC_1642089595.pdf

Reasons for updating

  • Change to section 6.3 - Shelf life

Legal category:Product subject to restricted prescription (C)

Updated on 12 March 2021

File name

PIL_1615566098.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 07 February 2021

File name

PIL_1612695535.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Free text change information supplied by the pharmaceutical company

Addition of Pronav Clinical Ltd. as manufacturer.

Updated on 08 June 2020

File name

Summary of Product Characteristics_1591610122.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to restricted prescription (C)

Updated on 08 June 2020

File name

Package Leaflet_1591609943.pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - excipient warnings
  • Change to section 3 - how to take/use

Updated on 17 December 2019

File name

Summary of product characteristics_1576596100.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Updated on 17 December 2019

File name

Package leaflet_1576596073.pdf

Reasons for updating

  • New PIL for new product